Dthera Sciences (OTCPK:DTHR.D) announced that it has entered into a securities purchase agreement with Ionic Ventures, LLC for a private placement of original issue discount senior convertible promissory note for gross proceeds of $1,000,000 on September 21, 2018. The note accrues no interest and would mature on March 21, 2019. The note is convertible into $0.001 per share par value common shares of the company at conversion price of $0.50 per share, subject to adjustment. The company also issued warrants to purchase 2,000,000 shares of the company at an exercise price of $0.65 per share for a period of 60 months and 1,000,000 shares of the company’s restricted common stock. The company will issue securities pursuant to exemption provided under Rule 506 of Regulation D.